The Current Ratio as of November 2024 (TTM) for Clene Inc. (CLNN) is 0.99

According to Clene Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.99. This represents a change of -41.48% compared to the average of 1.70 of the last 4 quarters.

Clene Inc. (CLNN) Historical Current Ratio (quarterly & annually)

How has CLNN Current Ratio performed in the past?

The mean historical Current Ratio of Clene Inc. over the last ten years is 3.41. The current 0.99 Current Ratio has changed 2.82% with respect to the historical average. Over the past ten years (40 quarters), CLNN's Current Ratio was at its highest in in the June 2021 quarter at 15.08. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Clene Inc. (CLNN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Clene Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clene Inc. (CLNN) Average Current Ratio

How has CLNN Current Ratio performed in the past?

The current Current Ratio of Clene Inc. (CLNN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Clene Inc. (CLNN) Current Ratio vs. Peers

How is CLNN’s Current Ratio compared to its peers?

Clene Inc.’s Current Ratio is less than MediciNova, Inc. (0), less than Eliem Therapeutics, Inc. (18.24), less than Molecular Partners AG (60.41), less than Champions Oncology, Inc. (14.58), greater than Cyteir Therapeutics, Inc. (0.69), less than Century Therapeutics, Inc. (21.89), less than Kezar Life Sciences, Inc. (10.62), less than Mineralys Therapeutics, Inc. (9.58), less than Nkarta, Inc. (11.20), less than NGM Biopharmaceuticals, Inc. (15.91), less than Ikena Oncology, Inc. (7.79), less than Foghorn Therapeutics Inc. (18.22), less than Werewolf Therapeutics, Inc. (5.69), less than Immunome, Inc. (12.13), less than Sensei Biotherapeutics, Inc. (7.12), less than NextCure, Inc. (10.90), less than Nuvation Bio Inc. (8.35), less than Graphite Bio, Inc. (11.49), less than Merrimack Pharmaceuticals, Inc. (11.47), less than null (10.78),

Build a custom stock screener for Clene Inc. (CLNN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clene Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clene Inc. (CLNN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.